Immix Biopharma, Inc. (IMMX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$29.4M

Total Assets (FY2025)

$104.8M

Total Equity (FY2025)

$93.8M

Cash Flows from Operating Activities (FY2025)

-$23.9M

Source: Immix Biopharma, Inc. 10-K/A filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.